Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals potential growth. Read why RADX stock is a Hold.

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

The pair appeared on the Stick To Football podcast, brought to you by Sky Bet, where Caragh opened up about life with her ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Analysts expect ImmunoPrecise Antibodies to report an earnings per share (EPS) of $-0.06. Investors in ImmunoPrecise Antibodies are eagerly awaiting the company's announcement, hoping for news of ...

Acumen Pharmaceuticals has concluded enrolment for its multi-centre, double-blind Phase II ALTITUDE-AD trial of humanised ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

The general mood among these heavyweight investors is divided, with 25% leaning bullish and 62% bearish. Among these notable ...

Avian influenza has been confirmed in wild bobcats in New York state, according to a new study from Cornell University.

Antibodies taken from alpacas are to be used in a new pandemic flu drug, in a £33 million project led by AstraZenica.

ImmunoPrecise Antibodies (NASDAQ:IPA – Get Free Report) is anticipated to announce its earnings results before the market ...